A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Study Identifier
206207-014
CT.gov Identifier
NCT00333814
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Uveitis
    • Study Drug
  • Dexamethasone
  • dexamethasone
  • Sham injection
    • Phase
    Phase 2/Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * 18 years or older with a diagnosis of chronic intermediate uveitis in at least one eye
    Exclusion Criteria:
    * Uncontrolled systemic disease * Any active ocular infections

    Protocol Summary

    This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious intermediate or posterior uveitis.

    Study Locations

    Location
    Status
    Location
    Dallas, Texas, United States
    Status
    Not applicable
    Location
    Sydney, Australia
    Status
    Not applicable
    Location
    Vienna, Austria
    Status
    Not applicable
    Location
    São Paulo, São Paulo/SP, Brazil
    Status
    Not applicable
    Location
    Montreal, Quebec, Canada
    Status
    Not applicable
    Location
    Prague, Czech Republic
    Status
    Not applicable
    Showing {first} - {last} of {total} Results